KRAS and urinary bladder carcinoma: Ankfn1, Gstt2, Plec, Gphn, Fmo5, Cmss1, Ahnak, Mecom, Slc2a1, Gsta4, Kras, Peak1, and Hmga2 were associated with worse disease-free survival in bladder cancer patients (Figure 5B).